Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-27 · accession 0001735276-23-000081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-27 | ALNY | BONNEY MICHAEL W | Dir | S - Sale+OE | $195.00 | -30.0K | 16.0K | -65% | -$5.85M |
| D | 2023-12-29 | 2023-12-27 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $96.45 | +30.0K | 46.0K | +187% | +$2.89M |
| D | 2023-12-29 | 2023-12-27 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | S | D | 30,000 | $195.00 | 16,029 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-27 | M | A | 30,000 | $96.45 | 46,029 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-27 | M | D | 30,000 | $0.00 | 0 | D | $96.45 · — to 2024-12-17 | 30,000 Common Stock | (F3) The stock option was fully vested as of 12/17/2017. |